Metropolis Healthcare is currently trading at Rs. 1883.30, up by 83.95 points or 4.67% from its previous closing of Rs. 1799.35 on the BSE.
The scrip opened at Rs. 1864.00 and has touched a high and low of Rs. 1935.00 and Rs. 1850.55 respectively. So far 267666 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1,935.00 on 12-Apr-2024 and a 52 week low of Rs. 1209.25 on 22-May-2023.
Last one week high and low of the scrip stood at Rs. 1935.00 and Rs. 1679.30 respectively. The current market cap of the company is Rs. 9647.55 crore.
The promoters holding in the company stood at 49.74%, while Institutions and Non-Institutions held 42.39% and 7.87% respectively.
Metropolis Healthcare has reported around 15% growth Year-on-Year (Y-o-Y) in core business revenue during fourth quarter of FY24. Its core revenue growth was driven by volume growth around 8% and Revenue Per Patient (RPP) growth at 7% YoY for Q4FY24. RPP growth was largely driven by growth in speciality tests segment, premium wellness segment and price increase. The company’s Business-to-Consumer (B2C) revenue grew at around 18% Y-o-Y for Q4FY24. Meanwhile, the company has become debt-free in Q4FY24.
Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7236.35 |
Max Healthcare Inst | 1193.20 |
Narayana Hrudayalay | 1280.95 |
Aster DM Healthcare | 494.95 |
Global Health | 1133.80 |
View more.. |